Nascent transcription upon interferon-α2 stimulation on human and rhesus macaque lymphoblastoid cell lines

© 2023. The Author(s)..

OBJECTIVES: The interferon-triggered innate immune response has been observed to be under strong diversifying selection to counteract the many pathogens hosts have to defend against. In particular, rewiring of gene transcription regulation allows organisms to rapidly acquire new phenotypes by removing and adding genes into the innate immune gene network. Dissecting the molecular processes by which this rewiring takes place, either by changing the DNA regulatory elements or by changing the activity of the regulators across species, is key to better understand this evolutionary process.

DATA DESCRIPTION: To better comprehend the evolutionary dynamics that have occurred in the initial transcriptional response to interferon in primates, we present Precision Run-On (PRO-seq) datasets made after 1 h of interferon-α2 stimulation on human and rhesus macaque lymphoblastoid cell lines. Further, we tested the difference between using either species' cognate interferon versus using the other orthologous interferon to account for any potential impacts in the interaction of the orthologous interferons with their cellular membrane receptors. This data provides insights into the regulatory mechanisms that drive species-specific responses to environmental perturbations, such as the one driven by the interactions of pathogens and their hosts.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:16

Enthalten in:

BMC research notes - 16(2023), 1 vom: 26. Okt., Seite 292

Sprache:

Englisch

Beteiligte Personen:

Ramirez, Daniel [VerfasserIn]
B Chuong, Edward [VerfasserIn]
D Dowell, Robin [VerfasserIn]

Links:

Volltext

Themen:

9008-11-1
Homo sapiens
Interferons
Journal Article
Lymphoblastoid cell lines
Macaca mulatta
PRO-seq
Type I interferon

Anmerkungen:

Date Completed 30.10.2023

Date Revised 10.02.2024

published: Electronic

Citation Status MEDLINE

doi:

10.1186/s13104-023-06465-1

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM363771123